JT
XENE icon

Jupiter Topco’s Xenon Pharmaceuticals XENE Stock Holding History

Jupiter Topco’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253M Buy
+4,186,519
New +$232M 0.1% 187

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jupiter Topco's XENE Position: Q2 2026 in Review

Jupiter Topco opened a new position in Xenon Pharmaceuticals (XENE) in Q2 2026: 4,186,519 shares worth $253M. The stake represents 0.1% of the portfolio and ranks #187 among its holdings.

286 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Jupiter Topco held 4,186,519 shares of Xenon Pharmaceuticals worth $253M as of Q2 2026.
  • Xenon Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Xenon Pharmaceuticals made up 0.1% of Jupiter Topco's portfolio in Q2 2026, its #187 holding.
  • 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.